Rita Schmid, MD
Internal Medicine · South Bend, INNPI 1306057724
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Novo Nordisk at 42.4% of the total. That places this record below the midpoint for internal medicine clinicians in IN, where the typical reported total is $172.
Across 11 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$97
- Insulet Corporation$29
- Amgen$29
- GSK$22
- Inspire Medical Systems, Inc.$20
- AbbVie$16
- plus $15 from 1 others
Across 108 payments — averaging $5544.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$272K
- Regeneron$259K
- GSK$68K
What the payments were for
- Food & beverage$228100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 4 | $97 |
| Insulet Corporation | 1 | $29 |
| Amgen | 2 | $29 |
| GSK | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| AbbVie | 1 | $16 |
| Terumo Medical Corporation | 1 | $15 |
How this compares
$228 in reported general payments places this provider in the 50th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 87 | $129,793 |
| EliquisApixaban | 52 | $56,571 |
| TrulicityDulaglutide | 44 | $47,224 |
| JardianceEmpagliflozin | 24 | $35,044 |
| InvokanaCanagliflozin | 26 | $24,943 |
| JanuviaSitagliptin Phosphate | 23 | $24,008 |
| MounjaroTirzepatide | 21 | $23,072 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $17,920 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $13,087 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $9,893 |
| SynthroidLevothyroxine Sodium | 125 | $8,835 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $7,493 |
| Levothyroxine Sodium | 861 | $6,798 |
| Atorvastatin Calcium | 728 | $5,779 |
| Humalog Kwikpen U-100Insulin Lispro | 21 | $5,628 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $97 | $129,79387 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $22 | $35,67650 claims |
| AbbVieSynthroid | $16 | $8,835125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in South Bend
- Abhinav SinghGreenwood$733K
- Girish KunapareddyTerre Haute$329K
- Raj VuppalanchiIndianapolis$279K
- Joseph Arulandula Porte$251K
- Napoleon MamintaIndianapolis$116K
- Jennifer PaisleyLawrenceburg$112K
- Allon FriedmanIndianapolis$111K
- John AyresIndianapolis$107K
- Emily FrankLebanon$100K
- David IloFort Wayne$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.